JP2025508660A5 - - Google Patents

Info

Publication number
JP2025508660A5
JP2025508660A5 JP2024543311A JP2024543311A JP2025508660A5 JP 2025508660 A5 JP2025508660 A5 JP 2025508660A5 JP 2024543311 A JP2024543311 A JP 2024543311A JP 2024543311 A JP2024543311 A JP 2024543311A JP 2025508660 A5 JP2025508660 A5 JP 2025508660A5
Authority
JP
Japan
Application number
JP2024543311A
Other languages
Japanese (ja)
Other versions
JP2025508660A (ja
JPWO2023156970A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2023/051467 external-priority patent/WO2023156970A1/en
Publication of JP2025508660A publication Critical patent/JP2025508660A/ja
Publication of JP2025508660A5 publication Critical patent/JP2025508660A5/ja
Publication of JPWO2023156970A5 publication Critical patent/JPWO2023156970A5/ja
Pending legal-status Critical Current

Links

JP2024543311A 2022-02-18 2023-02-17 2-ヒドロキシプロピル-β-シクロデキストリンによる高トリグリセリド血症の治療 Pending JP2025508660A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263311536P 2022-02-18 2022-02-18
US63/311,536 2022-02-18
PCT/IB2023/051467 WO2023156970A1 (en) 2022-02-18 2023-02-17 Treatment of hypertriglyceridemia with 2-hydroxypropyl-beta-cyclodextrin

Publications (3)

Publication Number Publication Date
JP2025508660A JP2025508660A (ja) 2025-04-10
JP2025508660A5 true JP2025508660A5 (https=) 2026-02-24
JPWO2023156970A5 JPWO2023156970A5 (https=) 2026-02-24

Family

ID=85476260

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024543311A Pending JP2025508660A (ja) 2022-02-18 2023-02-17 2-ヒドロキシプロピル-β-シクロデキストリンによる高トリグリセリド血症の治療

Country Status (11)

Country Link
US (1) US20240398849A1 (https=)
EP (1) EP4479064A1 (https=)
JP (1) JP2025508660A (https=)
KR (1) KR20240148426A (https=)
CN (1) CN118715017A (https=)
AU (1) AU2023222567A1 (https=)
CA (1) CA3244447A1 (https=)
IL (1) IL315046A (https=)
MX (1) MX2024010110A (https=)
TW (1) TW202342072A (https=)
WO (1) WO2023156970A1 (https=)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0307518A (pt) * 2002-02-01 2004-12-28 Shimoda Biotech Pty Ltd Composição farmacêutica
CN1745746A (zh) * 2004-09-09 2006-03-15 天津药物研究院 冰片的羟丙基-β-环糊精包合物及其制剂和制备方法
CN1961892A (zh) * 2005-11-08 2007-05-16 天津药物研究院 降香羟丙基-β-环糊精包合物及其制剂和制备方法
GB0710439D0 (en) * 2007-05-31 2007-07-11 Uni I Oslo Oral dosage form
JP5847721B2 (ja) * 2009-10-08 2016-01-27 ソン、ホ、バイオメッド、カンパニー、リミテッドSong Ho Biomed Co., Ltd 高水溶性2−ヒドロキシプロピル−ベータシクロデキストリンを有効成分として含有する、肥満疾患の予防および治療用組成物
FR3014694B1 (fr) * 2013-12-13 2016-11-11 Roquette Freres Compositions a base de methyl-cyclodextrines pour le traitement et/ou la prevention de maladies par augmentation du taux de cholesterol-hdl

Similar Documents

Publication Publication Date Title
BR102022025291A2 (https=)
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
BR102023001877A2 (https=)
BR102023000289A2 (https=)
BR102022026909A2 (https=)
BR102022023461A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
BY13150U (https=)
BY13160U (https=)
BY13140U (https=)
BY13141U (https=)
BY13142U (https=)
BY13143U (https=)
BY13144U (https=)
BY13145U (https=)
BY13149U (https=)
BY13166U (https=)